Peginterferon plus ribavirin and sustained virological response rate in HCV-related advanced fibrosis: a real life study

BACKGROUND: Tolerance and response to antiviral HCV treatment is poor in advanced fibrosis. The aim of this study was to assess SVR rate and its predictive factors in HCV advanced fibrosis patients treated in real life with full dose PEG-IFN plus RBV and to evaluate the adverse events related to tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Giovanni Faria, Villela-Nogueira, Cristiane A., Mello, Carlos Eduardo Brandão, Soares, Elza Cotrim, Coelho, Henrique Sergio M., Ferreira, Paulo Roberto Abrão, Ruiz, Fernando José Goes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425191/
https://www.ncbi.nlm.nih.gov/pubmed/24055310
http://dx.doi.org/10.1016/j.bjid.2013.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425191/
https://www.ncbi.nlm.nih.gov/pubmed/24055310
http://dx.doi.org/10.1016/j.bjid.2013.05.007

Ejemplares similares